Emisphere Technologies Announces Financial and Operational Results for the Third Quarter and First Nine Months of 2010
10 nov. 2010 17h00 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., Nov. 10, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced financial and operational results for the three and nine months ended September 30,...
Emisphere Technologies, Inc. Announces Third Quarter 2010 Earnings Conference Call
04 nov. 2010 09h00 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., Nov. 4, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that management will host a conference call to discuss the Company's financial and...
Emisphere Technologies Reports Notification of Top Level Results on Phase III Study of Oral Calcitonin in Osteoarthritis Patients
22 oct. 2010 09h00 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., Oct. 22, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that Novartis Pharma AG ("Novartis") provided Emisphere with information regarding the...
Emisphere Reports Positive Clinical Results for Its Oral Drug Delivery Technology in Appetite Suppression Study
17 sept. 2010 08h45 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., Sept. 17, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that a clinical study found that the company's proprietary oral SNAC (Sodium...
Emisphere Technologies to Present at Rodman & Renshaw 12th Annual Healthcare Conference
07 sept. 2010 09h58 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., Sept. 7, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and...
Emisphere Technologies Announces Agreements to Raise $7 Million in Private Placement Transactions
25 août 2010 09h20 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., Aug. 25, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that on August 25, 2010, Emisphere Technologies, Inc. (the "Company") entered into a...
Emisphere Announces Financial and Operational Results for the Second Quarter and First Six Months of 2010
16 août 2010 09h00 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., Aug. 16, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced financial and operational results for the three and six months ended June 30,...
Emisphere Announces Second Quarter 2010 Earnings Conference Call
09 août 2010 09h53 HE
|
Emisphere Technologies, Inc.
Conference Call/Webcast to be Held Monday, August 16, 2010 at 10:00 AM EDT
CEDAR KNOLLS, N.J., Aug. 9, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that...
Emisphere Provides an Update on Osteoarthritis Phase III Study With Oral Calcitonin
23 juil. 2010 08h40 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., July 23, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) today announced that Novartis Pharma AG and its license partner Nordic Bioscience a/s (the "Sponsor")...
Emisphere Technologies Provides Update on High Dose Oral Eligen(R) B12
16 juil. 2010 16h23 HE
|
Emisphere Technologies, Inc.
CEDAR KNOLLS, N.J., July 16, 2010 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB:EMIS) announced today that it is engaged in ongoing discussions with a potential licensee for its high dose...